BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 19234211)

  • 1. Herpesvirus entry mediator-Ig treatment during immunization aggravates rheumatoid arthritis in the collagen-induced arthritis model.
    Pierer M; Schulz A; Rossol M; Kendzia E; Kyburz D; Haentzschel H; Baerwald C; Wagner U
    J Immunol; 2009 Mar; 182(5):3139-45. PubMed ID: 19234211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
    Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
    Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
    Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for HVEM, but not lymphotoxin-beta receptor, in LIGHT-induced tumor cell death and chemokine production.
    Pasero C; Barbarat B; Just-Landi S; Bernard A; Aurran-Schleinitz T; Rey J; Eldering E; Truneh A; Costello RT; Olive D
    Eur J Immunol; 2009 Sep; 39(9):2502-14. PubMed ID: 19701890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
    Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
    Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation.
    Cai G; Freeman GJ
    Immunol Rev; 2009 May; 229(1):244-58. PubMed ID: 19426226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator.
    Cai G; Anumanthan A; Brown JA; Greenfield EA; Zhu B; Freeman GJ
    Nat Immunol; 2008 Feb; 9(2):176-85. PubMed ID: 18193050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation.
    Steinberg MW; Cheung TC; Ware CF
    Immunol Rev; 2011 Nov; 244(1):169-87. PubMed ID: 22017438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT.
    Kojima R; Kajikawa M; Shiroishi M; Kuroki K; Maenaka K
    J Mol Biol; 2011 Nov; 413(4):762-72. PubMed ID: 21959263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.
    Sedy JR; Gavrieli M; Potter KG; Hurchla MA; Lindsley RC; Hildner K; Scheu S; Pfeffer K; Ware CF; Murphy TL; Murphy KM
    Nat Immunol; 2005 Jan; 6(1):90-8. PubMed ID: 15568026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of graft arterial disease by manipulation of the LIGHT pathway.
    Kosuge H; Suzuki J; Kakuta T; Haraguchi G; Koga N; Futamatsu H; Gotoh R; Inobe M; Isobe M; Uede T
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1409-15. PubMed ID: 15178556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major.
    Xu G; Liu D; Okwor I; Wang Y; Korner H; Kung SK; Fu YX; Uzonna JE
    J Immunol; 2007 Nov; 179(10):6901-9. PubMed ID: 17982081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].
    Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis.
    Murakami Y; Akahoshi T; Aoki N; Toyomoto M; Miyasaka N; Kohsaka H
    Arthritis Rheum; 2009 Jun; 60(6):1615-23. PubMed ID: 19479878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM.
    Murphy TL; Murphy KM
    Annu Rev Immunol; 2010; 28():389-411. PubMed ID: 20307212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of myocarditis by HVEM-overexpressing dendritic cells through induction of IL-10-producing cells.
    Cai G; Wang H; Qin Q; Zhang J; Zhu Z; Liu M; Shen Q
    Cardiovasc Res; 2009 Dec; 84(3):425-33. PubMed ID: 19570810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (5R)-5-hydroxytriptolide attenuated collagen-induced arthritis in DBA/1 mice via suppressing interferon-gamma production and its related signaling.
    Zhou R; Tang W; Ren YX; He PL; Zhang F; Shi LP; Fu YF; Li YC; Ono S; Fujiwara H; Yang YF; Zuo JP
    J Pharmacol Exp Ther; 2006 Jul; 318(1):35-44. PubMed ID: 16574782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
    Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoy receptor 3 attenuates collagen-induced arthritis by modulating T cell activation and B cell expansion.
    Cheng CP; Sytwu HK; Chang DM
    J Rheumatol; 2011 Dec; 38(12):2522-35. PubMed ID: 21885501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.